Market Overview:
The global gibberellins market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to factors such as rising geriatric population, increasing prevalence of chronic diseases, and technological advancements in telemonitoring systems. Based on type, the global gibberellins market is segmented into COPD telemonitoring system, glucose level telemonitoring system, blood pressure telemonitoring system, cardiac & monitoring systems, and others. The COPD telemonitoring system segment is expected to grow at a CAGR of 6.1% during the forecast period from 2018 to 2030. This growth can be attributed to increasing incidence of COPD and growing demand for home care services across the globe. Based on application, the global gibberellins market is segmented into home care services, long-term care centers (LTC), and hospital cares segments. The home care services segment accounted for majority share of 49% in 2017 and is projected to grow at a CAGR of 5%.
Product Definition:
Gibberellins are a class of plant hormones that stimulate growth and development. They are important for seed germination, stem elongation, and floral induction.
COPD Telemonitoring System:
The global COPD telemonitoring system, it's usage and growth factor in the gibberellins market is a study carried out to determine the current level of awareness regarding COPD telemonitoring systems among key industry participants. The study also determines the degree of adoption & penetration of these devices amongst end-users.
Glucose Level Telemonitoring System:
Glucose level monitoring is a system that measures the blood sugar level in humans. It is used as an aid to treat diabetes and also helps monitor the effectiveness of treatment. The device works on the principle of detecting changes in glucose levels by sensing tiny variations in electrical signals produced by sugar molecules present within body fluids such as urine, blood or saliva.
Application Insights:
The global gibberellins market is segmented by application into home care, long-term care centers, and hospital/medicalcare. The hospital/medicalcare segment dominated the overall market in 2017 due to a high prevalence of chronic diseases such as cancer and diabetes which require regular monitoring. Moreover, an increase in geriatric population group with associated health issues is expected to drive the demand for medical telemetry devices over the forecast period.
The home care segment was valued at USD 536.3 million in 2017 owing to increasing geriatric population groups requiring around-the-clock assistance with daily activities which has resulted in increased number of incontinence cases across various regions globally including North America and Europe.
Regional Analysis:
North America accounted for the largest revenue share in 2017. The region is expected to maintain its dominance over the forecast period owing to increasing prevalence of COPD and other chronic diseases, such as diabetes, cardiac disorders, and hypertension. In addition, technological advancements in monitoring systems are also expected to drive the market growth during the forecast period.
Asia Pacific is anticipated to witness lucrative growth over the coming years due to rising geriatric population base that requires continuous care & medical monitoring at home or a long-term care center. Moreover, growing healthcare expenditure by governments along with an increase in awareness about telehealth services will further boost industry expansion over this region has potential growth opportunities for new segments as well as applications of gerberellins market over next eight years (2030).
Growth Factors:
- Increasing demand for quality fruits and vegetables from the burgeoning middle-class population in developing countries is expected to drive the growth of gibberellins market over the forecast period.
- Rising awareness about the benefits of gibberellins among farmers is projected to boost demand for these products over the next few years.
- Growing adoption of modern agricultural practices, such as use of fertilizers and pesticides, is anticipated to fuel growth of gibberellins market in near future.
- Increasing research and development activities by key players for new product launches is likely to propel growth of this market in coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Gibberellins Market Research Report
By Type
COPD Telemonitoring System, Glucose Level Telemonitoring System, Blood Pressure Telemonitoring System, Cardiac & Monitoring Systems, Others
By Application
Home Care, Long-term Care Centers, Hospital Cares
By Companies
Abbott Laboratories, General Electric, McKesson Corporation, Koninklijke Philips N.V., Aerotel Medical Systems Ltd., Advanced TeleHealth Solutions, Honeywell Life Care Solutions, Medtronic PLC, LifeWatch AG, Allscripts Healthcare Solutions Inc., SHL Telemedicine, Siemens Healthineers AG., Biotronik Inc., Nihon Kohden Corporation
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
244
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Gibberellins Market Report Segments:
The global Gibberellins market is segmented on the basis of:
Types
COPD Telemonitoring System, Glucose Level Telemonitoring System, Blood Pressure Telemonitoring System, Cardiac & Monitoring Systems, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Home Care, Long-term Care Centers, Hospital Cares
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Laboratories
- General Electric
- McKesson Corporation
- Koninklijke Philips N.V.
- Aerotel Medical Systems Ltd.
- Advanced TeleHealth Solutions
- Honeywell Life Care Solutions
- Medtronic PLC
- LifeWatch AG
- Allscripts Healthcare Solutions Inc.
- SHL Telemedicine
- Siemens Healthineers AG.
- Biotronik Inc.
- Nihon Kohden Corporation
Highlights of The Gibberellins Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- COPD Telemonitoring System
- Glucose Level Telemonitoring System
- Blood Pressure Telemonitoring System
- Cardiac & Monitoring Systems
- Others
- By Application:
- Home Care
- Long-term Care Centers
- Hospital Cares
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Gibberellins Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Gibberellins are a group of plant hormones that regulate the growth and development of plants. Gibberellins help to promote the production of new leaves, flowers, and fruit.
Some of the major players in the gibberellins market are Abbott Laboratories, General Electric, McKesson Corporation, Koninklijke Philips N.V., Aerotel Medical Systems Ltd., Advanced TeleHealth Solutions, Honeywell Life Care Solutions, Medtronic PLC, LifeWatch AG, Allscripts Healthcare Solutions Inc., SHL Telemedicine, Siemens Healthineers AG., Biotronik Inc., Nihon Kohden Corporation.
The gibberellins market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Gibberellins Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Gibberellins Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Gibberellins Market - Supply Chain
4.5. Global Gibberellins Market Forecast
4.5.1. Gibberellins Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Gibberellins Market Size (000 Units) and Y-o-Y Growth
4.5.3. Gibberellins Market Absolute $ Opportunity
5. Global Gibberellins Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Gibberellins Market Size and Volume Forecast by Type
5.3.1. COPD Telemonitoring System
5.3.2. Glucose Level Telemonitoring System
5.3.3. Blood Pressure Telemonitoring System
5.3.4. Cardiac & Monitoring Systems
5.3.5. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Gibberellins Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Gibberellins Market Size and Volume Forecast by Application
6.3.1. Home Care
6.3.2. Long-term Care Centers
6.3.3. Hospital Cares
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Gibberellins Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Gibberellins Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Gibberellins Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Gibberellins Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Gibberellins Demand Share Forecast, 2019-2026
9. North America Gibberellins Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Gibberellins Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Gibberellins Market Size and Volume Forecast by Application
9.4.1. Home Care
9.4.2. Long-term Care Centers
9.4.3. Hospital Cares
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Gibberellins Market Size and Volume Forecast by Type
9.7.1. COPD Telemonitoring System
9.7.2. Glucose Level Telemonitoring System
9.7.3. Blood Pressure Telemonitoring System
9.7.4. Cardiac & Monitoring Systems
9.7.5. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Gibberellins Demand Share Forecast, 2019-2026
10. Latin America Gibberellins Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Gibberellins Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Gibberellins Market Size and Volume Forecast by Application
10.4.1. Home Care
10.4.2. Long-term Care Centers
10.4.3. Hospital Cares
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Gibberellins Market Size and Volume Forecast by Type
10.7.1. COPD Telemonitoring System
10.7.2. Glucose Level Telemonitoring System
10.7.3. Blood Pressure Telemonitoring System
10.7.4. Cardiac & Monitoring Systems
10.7.5. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Gibberellins Demand Share Forecast, 2019-2026
11. Europe Gibberellins Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Gibberellins Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Gibberellins Market Size and Volume Forecast by Application
11.4.1. Home Care
11.4.2. Long-term Care Centers
11.4.3. Hospital Cares
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Gibberellins Market Size and Volume Forecast by Type
11.7.1. COPD Telemonitoring System
11.7.2. Glucose Level Telemonitoring System
11.7.3. Blood Pressure Telemonitoring System
11.7.4. Cardiac & Monitoring Systems
11.7.5. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Gibberellins Demand Share, 2019-2026
12. Asia Pacific Gibberellins Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Gibberellins Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Gibberellins Market Size and Volume Forecast by Application
12.4.1. Home Care
12.4.2. Long-term Care Centers
12.4.3. Hospital Cares
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Gibberellins Market Size and Volume Forecast by Type
12.7.1. COPD Telemonitoring System
12.7.2. Glucose Level Telemonitoring System
12.7.3. Blood Pressure Telemonitoring System
12.7.4. Cardiac & Monitoring Systems
12.7.5. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Gibberellins Demand Share, 2019-2026
13. Middle East & Africa Gibberellins Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Gibberellins Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Gibberellins Market Size and Volume Forecast by Application
13.4.1. Home Care
13.4.2. Long-term Care Centers
13.4.3. Hospital Cares
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Gibberellins Market Size and Volume Forecast by Type
13.7.1. COPD Telemonitoring System
13.7.2. Glucose Level Telemonitoring System
13.7.3. Blood Pressure Telemonitoring System
13.7.4. Cardiac & Monitoring Systems
13.7.5. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Gibberellins Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Gibberellins Market: Market Share Analysis
14.2. Gibberellins Distributors and Customers
14.3. Gibberellins Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Abbott Laboratories
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. General Electric
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. McKesson Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Koninklijke Philips N.V.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Aerotel Medical Systems Ltd.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Advanced TeleHealth Solutions
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Honeywell Life Care Solutions
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Medtronic PLC
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. LifeWatch AG
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Allscripts Healthcare Solutions Inc.
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. SHL Telemedicine
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Siemens Healthineers AG.
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Biotronik Inc.
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Nihon Kohden Corporation
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
